Introduction
============

Extracytoplasmic function sigma factors are the largest and most diverse family of sigma factors in bacteria, directing expression of genes in response to a wide range of environmental stimuli ([@B36]; [@B15]; [@B26]). The activities of most ECF sigma factors are controlled by antisigma proteins that bind to and inhibit their cognate sigma factors ([@B7]; [@B30]). CSS systems control the activities of a large proportion of the ECF sigma factors in Gram negative bacteria. In CSS systems antisigma protein activity (and hence that of the cognate ECF sigma factor) is controlled by an outer membrane protein receptor in response to an extracellular chemical signal, commonly a ferrisiderophore ([@B40]; [@B5]; [@B25]). One of the best-characterized CSS systems controls expression of genes for synthesis of a siderophore pyoverdine and subsequent uptake of ferripyoverdine in the opportunistic pathogen *Pseudomonas aeruginosa* (**Figure [1](#F1){ref-type="fig"}**). In this system sigma factors σ^FpvI^ and σ^PvdS^ are inhibited by antisigma protein FpvR~20~ that is formed by cleavage of a 37 kDa precursor protein ([@B10]). FpvR~20~ extends from the periplasm through the cytoplasmic membrane into the cytoplasm and inhibition involves binding of the sigma factors by FpvR~20~, which also causes degradation of σ^PvdS^ although not σ^FpvI^ ([@B35]; [@B12], [@B11]). Importation of ferripyoverdine results in molecular rearrangement of its receptor, FpvA ([@B32]), initiating a proteolytic cascade that results in complete degradation of FpvR~20~. σ^FpvI^ and σ^PvdS^ then direct expression of genes for synthesis of FpvA and pyoverdine, respectively. σ^PvdS^ also directs expression of genes encoding a secreted exotoxin and a protease ([@B23]). The rate of induction of target gene expression in response to the appropriate environmental signal has not been determined for this or any other CSS pathway.

![The pyoverdine signaling pathway. **(A)** In the absence of ferripyoverdine the activities of sigma factors σ^FpvI^ and σ^PvdS^ are inhibited by the antisigma protein FpvR~20~. **(B)** Import of ferripyoverdine (Fe-PVD) causes a molecular rearrangement of the FpvA receptor protein, triggering a proteolytic cascade that degrades FpvR~20~. σ^FpvI^ and σ^PvdS^ then become active, stimulating expression of the *fpvA* gene and of pyoverdine (pvd) synthesis genes, respectively. See text and ([@B25]) for more detailed information. OM, outer membrane; CM, cytoplasmic membrane.](fmicb-08-02442-g001){#F1}

The molecular mechanisms underlying signal transduction in CSS pathways are only partially understood. The proteolytic cascade that leads to degradation of FpvR~20~ includes the cytoplasmic membrane protease RseP but the other proteases involved have not yet been identified ([@B10]). RseP and its homologs are also required for cleavage of other antisigma proteins that inhibit ECF sigma factors ([@B21]; [@B10]; [@B9]; [@B2]). The periplasmic protease Prc is part of the proteolytic cascade in other CSS systems ([@B3]) but is not required for signal transduction in the pyoverdine system ([@B10]). The protease(s) required for degradation of the cytoplasmic antisigma component and consequent sigma factor activity are not yet known in this or any other CSS pathway.

The simplest model for induction of gene expression in sigma-antisigma systems is that degradation of antisigma protein releases active sigma factor that can then interact with core RNA polymerase to initiate transcription from target promoters. To the best of our knowledge this model has not been tested experimentally. A possible alternative mechanism, suggested by proteolysis of σ^PvdS^ in the presence of FpvR~20~, is that sigma factors are inactivated following binding by antisigma proteins and are only active when synthesized in the absence of the cognate antisigma.

The aims of the work described here were to investigate the time-course of degradation of FpvR~20~ and consequent induction of target gene expression in response to the ferripyoverdine inducing signal; to identify the protease responsible for degrading the cytoplasmic portion of FpvR~20~; and to investigate whether active σ^PvdS^ and σ^FpvI^ sigma factors are released following proteolysis of FpvR~20~, or whether sigma factors must be synthesized in the absence of FpvR~20~ to be active.

Materials and Methods {#s1}
=====================

Growth of Bacteria
------------------

Strains of *P. aeruginosa* used in this study are listed in **Table [1](#T1){ref-type="table"}**. Bacteria were routinely grown in LB medium or on LB agar at 37°C. For Western blotting and reverse transcription quantitative PCR (RT-qPCR) *P. aeruginosa* was grown in King's B medium ([@B20]). Antibiotics were added as required at the same concentrations as described previously ([@B28]) with chloramphenicol being added to a final concentration of 150 μg/mL that completely prevents protein synthesis ([@B19]).

###### 

Plasmids and strains of *Pseudomonas aeruginosa* used in this study.

  Plasmids                            Description                                                                                                                                                                                                 Reference
  ----------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  pEX18Gm                             *oriT*^+^ *sacB*^+^ gene replacement vector; Gm^R^                                                                                                                                                          [@B16]
  mini-CTX2                           Tc^R^, integrating vector                                                                                                                                                                                   [@B17]
  mini-CTX2*tigclpP*                  Mini-CTX2 containing 2.3 kb fragment spanning *tig* and *clpP* genes (PAO1 genome region 1952446--1954761)                                                                                                  This study
  pEX18Gm::Δ*clpP*                    Allele replacement plasmid for the removal of PAO1 genome region 1954077--1954699, 0.9 and 0.8 kb fragments flanking *clpP* cloned into pEX18Gm as *Hin*dIII-*Bam*HI-*EcoR*I restriction fragments, Gm^R^   This study
  pEX18Gm:: Δlon                      Allele replacement plasmid for the removal of PAO1 genome region 1956251--1959420, 0.9 and 0.8 kb fragments flanking *lon* cloned into pEX18Gm as *Hin*dIII-*Bam*HI-*EcoR*I restriction fragments, Gm^R^    This study
  Strains of *P. aeruginosa*                                                                                                                                                                                                                      
  PAO1                                Wild-type; Pvd^+^                                                                                                                                                                                           [@B37]
  PAO1 *pvdF*                         PAO1 *pvdF*::Km^R^; Pvd^-^                                                                                                                                                                                  [@B27]
  PAO1 *pvdF clpP*                    PAO1 *pvdF* with an unmarked *clpP* deletion                                                                                                                                                                This study
  PAO1 *pvdF clpP* (ctx::tig*clpP*)   PAO1 *pvdF clpP* containing mini-CTX2*tigclpP*                                                                                                                                                              This study
  PAO1 *pvdF lon*                     PAO1 *pvdF* with an unmarked lon deletion                                                                                                                                                                   This study

Genetic Manipulations
---------------------

Plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. Restriction of DNA molecules and DNA cloning were carried out using standard methods ([@B31]) with enzymes purchased from Roche Molecular Biologicals. DNA fragments required for strain construction were amplified from genomic DNA of *P. aeruginosa* PAO1 by PCR with FirePol DNA Polymerase (Solis Biodyne) or Taq DNA Polymerase Reddymix (ThermoPrime) using appropriate primers (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) that were designed on the basis of the *P. aeruginosa* PAO1 genome sequence^[1](#fn01){ref-type="fn"}^ ([@B41]). DNA fragments were cloned into the required vectors and all plasmid constructs were verified by DNA sequencing.

Construction of an unmarked deletion in the *P. aeruginosa clpP* gene was carried out as described previously ([@B16]; [@B28]; [@B10]). Briefly, fragments of DNA flanking the deletion site in *clpP* were amplified by PCR using primer pairs listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}, ligated together and cloned into the allele replacement vector pEX18Gm to give plasmid pEX18Gm::Δ*clpP*. Chromosomal allele replacement was then carried out ([@B16]). Over 90% of *clpP* was deleted and the deletion was in-frame with downstream genes. Deletions and allele replacements were confirmed by PCR. An analogous method was used to create a deletion in the *lon* gene. For complementation of the *clpP* mutation, a 2.3 kb PCR product spanning the *clpP* gene, the upstream *tig* gene and the predicted promoter was cloned into the integrating plasmid miniCTX2 ([@B17]) that was then transferred into *P. aeruginosa pvdF clpP* by conjugation from *Escherichia coli* S17-1 as described previously ([@B34]).

Western Blotting
----------------

Bacteria were grown in King's B medium ([@B20]) (20 mL) to late exponential phase (OD~600~ between 1.8 and 2.2 \[0.6 and 0.8 for PAO1 *pvdF clpP*\]). A sample (400 μL \[1000 μL for PAO1 *pvdF clpP*\]) was centrifuged in a bench-top microcentrifuge (13,000 rpm, 20 s) and the pellet resuspended in SDS--PAGE loading buffer \[2% (w/v) SDS, 5% (w/v) β-mercaptoethanol, 10% (v/v) glycerol, 0.002% bromophenol blue, 62.5 mM Tris--HCl; pH 6.8\] (15 μL \[8 μL for PAO1 *pvdF clpP*\]) and PBS (85 μL \[42 μL for PAO1 *pvdF clpP*\]) at 99°C. Pyoverdine (150 μM), purified from *P. aeruginosa* PAO1 as described previously ([@B28]), was added to each culture and samples were taken 1, 3, 5, 10, 20, 30, 60, 90, and 120 min after the addition of pyoverdine. The samples were centrifuged and the pellets resuspended as described above. The tubes were heated at 99°C for 20 min, centrifuged briefly and vortexed. Proteins were separated by electrophoresis on 12.5% SDS--PAGE gels and transferred to nitrocellulose membranes using standard methods ([@B14]). Membranes were blocked in 15% (v/v) SeaBlock (Pierce) in TBS buffer (0.9% NaCl, 100 mM Tris--HCl; pH 7.5) containing 0.1% (v/v) Tween. Blots were probed with monoclonal antibody anti-σ^PvdS^ ([@B42]) or anti-FpvRN ([@B10]) that was raised against a peptide corresponding to residues 62--75 within the N-terminal (cytoplasmic) region of FpvR~20~. Equal protein loadings were confirmed by probing the membranes with monoclonal antibody anti-RpoD (Santa Cruz Biotechnology). Detection was carried out using anti-Mouse HRP conjugates (Sigma), Super Signal ECL (Pierce), and a Fuji LAS-1000 Imager. Western blotting was carried out with bacteria from at least two independent cultures for each strain and growth condition and representative data are shown.

RT-qPCR
-------

Bacteria were grown at 37°C in King's B medium ([@B20]) (20 mL) to late exponential phase. A sample (500 μL) was taken from each culture (0 min) and transferred to a tube containing 1 mL of RNAprotect Bacteria Reagent (Qiagen). Pyoverdine (150 μM) was added to each culture. Samples (500 μL) were taken 5, 10, 30, and 60 min after the addition of pyoverdine. The samples were transferred to tubes containing 1 mL of RNAprotect Bacteria Reagent (Qiagen) and vortexed vigorously. RNA was extracted and RT-qPCR, including control reactions without template or without reverse transcriptase, was carried out as described previously ([@B10]; [@B22]). Relative quantification was performed using the second derivative maximum method corrected for primer efficiencies, with *clpX* and *oprL* as the combined reference genes, as described previously ([@B10]; [@B22]); the reference genes gave similar outcomes when used individually. qPCR was carried out twice for each cDNA sample, with three replicates each time. cDNA was prepared from at least two independent cultures for each strain and growth condition and representative data are shown.

Results
=======

Time Course for Induction of Gene Expression
--------------------------------------------

In the absence of ferripyoverdine, FpvR~20~ inhibits σ^PvdS^ and σ^FpvI^. Addition of pyoverdine, which chelates iron to become ferripyoverdine, induces σ^PvdS^-dependent expression of pyoverdine synthesis genes and the σ^FpvI^-dependent gene *fpvA* ([@B23]; [@B4]; [@B38]; [@B10]). However, the rate of increase in gene expression following addition of the inducing signal has not been determined for this or any other CSS system. We therefore determined the time-course of activation of transcription for two σ^PvdS^-dependent genes *pvdH* and *pvdL*, and the sole known σ^FpvI^-dependent gene *fpvA* (**Figure [2](#F2){ref-type="fig"}** and Supplementary Figure [S1](#SM2){ref-type="supplementary-material"}). *pvdH* and *pvdL* had very similar rates of induction, with maximal transcription 30 min after addition of pyoverdine. Expression of the *fpvA* gene was also maximal after 30 min although transcription of this gene was less strongly induced than that of *pvdH* and *pvdL*.

![Activation of gene expression following addition of pyoverdine. Pyoverdine was added to *Pseudomonas aeruginosa* PAO1 *pvdF* bacteria (0 min) and samples were collected at intervals and analyzed by reverse transcription quantitative PCR (RT-qPCR). The amounts of *pvdH*, *pvdL*, and *fpvA* transcripts are shown relative to the reference genes *clpX* and *oprL*. Data are means of six technical replicates with standard deviation shown. Similar results were obtained when the experiment was repeated (Supplementary Figure [S1](#SM2){ref-type="supplementary-material"}).](fmicb-08-02442-g002){#F2}

Degradation of FpvR~20~ and σ^PvdS^
-----------------------------------

σ^PvdS^ and σ^FpvI^ are inhibited by the FpvR~20~ protein and induction of gene expression following addition of pyoverdine requires degradation of FpvR~20~ ([@B10]). To determine the time-course of degradation of FpvR~20~, Western blotting was carried out using an antibody specific to the cytoplasmic (sigma factor binding) domain of the protein (**Figure [3A](#F3){ref-type="fig"}** and Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}). There was significantly less FpvR~20~ per cell within 1 min of addition of pyoverdine and FpvR~20~ was almost undetectable by 30 min. This timeframe correlates well with the induction of gene expression (**Figure [2](#F2){ref-type="fig"}**). Pyoverdine-mediated induction of gene expression is dependent on the FpvA ferripyoverdine receptor protein ([@B33]; [@B4]; [@B18]; [@B10]). Addition of pyoverdine to an *fpvA* mutant did not result in degradation of FpvR~20~ (**Figure [3B](#F3){ref-type="fig"}** and Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}) confirming the requirement for FpvA as well as pyoverdine for degradation of FpvR~20~.

![Time-course of degradation of FpvR~20~ and σ^PvdS^ following addition of pyoverdine. Pyoverdine was added to *P. aeruginosa* bacteria (0 min). Samples were collected at intervals and analyzed by Western blotting with antibodies against FpvR~20~, σ^PvdS^ or RpoD (loading control). FpvR~20~, σ^PvdS^ (full-size), PvdS~15~ and RpoD are indicated. Times are shown in minutes. **(A)** PAO1 *pvdF* **(B)** PAO1 *pvdF fpvA*. Similar results were obtained when the experiment was repeated (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}).](fmicb-08-02442-g003){#F3}

The presence of FpvR~20~ results in proteolysis of σ^PvdS^ to generate a subfragment (PvdS~15~) that is likely to be an intermediate in the proteolytic degradation of σ^PvdS^, lowering the amount of σ^PvdS^ per cell ([@B35]). The amount of PvdS~15~ decreased following the addition of pyoverdine (**Figure [3A](#F3){ref-type="fig"}**). In the absence of FpvA (and consequent presence of FpvR~20~) there was no change in the amount of PvdS~15~ following addition of pyoverdine (**Figure [3B](#F3){ref-type="fig"}**). These findings are consistent with the requirement of FpvR~20~ for degradation of σ^PvdS^ ([@B35]). The amount of σ^FpvI^ per cell is not altered by the presence of FpvR~20~ ([@B11]).

ClpP Protease Is Part of the Degradation Pathway
------------------------------------------------

Degradation of FpvR~20~ requires one or more cytoplasmic proteases ([@B10]). The cytoplasmic protease ClpP contributes to the degradation of the antisigma factors RseA in *E. coli* ([@B13]) and RsiW in *Bacillus subtilis* ([@B43]). We therefore tested the hypothesis that ClpP contributes to degradation of FpvR~20~ and consequent activity of σ^PvdS^ and σ^FpvI^. An in-frame deletion of the *clpP* (PA1801) gene was engineered in *P. aeruginosa* PAO1 *pvdF*. The effect of the *clpP* mutation on gene expression was then determined (**Figure [4](#F4){ref-type="fig"}** and Supplementary Figure [S3](#SM2){ref-type="supplementary-material"}). The *clpP* mutation completely prevented induction of expression of *pvdH*, *pvdL*, and *fpvA*. Indeed, gene expression in the *clpP* mutant was even lower than in Clp+ bacteria in the absence of pyoverdine. Complementation of the mutant with wild-type *clpP* restored gene expression. These data show that ClpP protease is essential for induction of gene expression in the pyoverdine signaling pathway.

![Effect of *clpP* mutation on induction of gene expression. Pyoverdine was added (0 min) to *P. aeruginosa* PAO1 *pvdF clpP* (black triangles) and *P. aeruginosa* PAO1 *pvdF clpP* (minictx::*tig-clpP*) (open triangles). Samples were collected at intervals and analyzed by RT-qPCR. Data are means of six technical replicates with standard deviation shown. Equivalent data from strain PAO1 *pvdF* bacteria (**Figure [2](#F2){ref-type="fig"}**) (black squares) are included for comparison. **(A)** *pvdH*. **(B)** *pvdL*. **(C)** *fpvA*.](fmicb-08-02442-g004){#F4}

We therefore tested the hypothesis that ClpP is required for degradation of FpvR~20~. Following addition of pyoverdine to *clpP* mutant bacteria, FpvR~20~ was degraded and a sub-fragment of approx. 12 kDa (FpvR~12~) was present that was not detected in Clp^+^ strains (**Figure [5A](#F5){ref-type="fig"}** and Supplementary Figure [S4](#SM2){ref-type="supplementary-material"}). The increasing amount of this fragment following addition of pyoverdine was inversely proportional to the decreasing amount of FpvR~20~ indicating that FpvR~12~ is formed as a result of proteolysis of FpvR~20~. The FpvR~12~ fragment retains the cytoplasmic sigma binding domain of FpvR~20~ ([@B12]) explaining the inhibition of sigma factor activity that occurs in the *clpP* mutant even when pyoverdine is present (**Figure [4](#F4){ref-type="fig"}**). Complementation with wild-type *clpP* restored wild-type phenotype of an absence of FpvR~12~ (**Figure [5B](#F5){ref-type="fig"}** and Supplementary Figure [S4](#SM2){ref-type="supplementary-material"}) and largely restored expression of the *pvdH*, *pvdL*, and *fpvA* genes (**Figure [4](#F4){ref-type="fig"}**); incomplete restoration of gene expression was most likely a consequence of the different chromosomal context of the introduced *clpP* gene. In contrast to ClpP^+^ bacteria, reduction in the amount of PvdS~15~ following addition of pyoverdine did not occur in the *clpP* mutant (**Figure [5A](#F5){ref-type="fig"}** and Supplementary Figure [S4](#SM2){ref-type="supplementary-material"}). Collectively these data show that ClpP protease is required for, and most likely catalyzes, degradation of the cytoplasmic portion of FpvR~20~.

![Effects of *clpP* mutation on degradation of FpvR~20~ and σ^PvdS^. Pyoverdine was added (0 min) to *P. aeruginosa* PAO1 *pvdF* bacteria containing a mutation in the *clpP* gene. Samples were collected at intervals and analyzed by Western blotting. Times are shown in minutes. **(A)** *P. aeruginosa* PAO1 *pvdF clpP*. **(B)** *P. aeruginosa* PAO1 *pvdF clpP* (minictx::*tig-clpP*). FpvR~20~, FpvR~12~, σ^PvdS^ (full-size), PvdS~15~ and RpoD are indicated. FpvR~12~ was not detected in *P. aeruginosa* PAO1 *pvdF clpP* (minictx::*tig-clpP*). Similar results were obtained when the experiment was repeated (Supplementary Figure [S4](#SM2){ref-type="supplementary-material"}).](fmicb-08-02442-g005){#F5}

Gene Expression Requires Newly Synthesized σ^PvdS^ But Not σ^FpvI^
------------------------------------------------------------------

The proteolytic degradation of σ^PvdS^ that occurs in the presence of FpvR~20~ raised the question, is active sigma factor released when FpvR~20~ is degraded or must the sigma factors be synthesized in the absence of FpvR~20~ to be active? To address this question, the effects of the translation inhibitor chloramphenicol on transcription of target genes were measured. If newly synthesized sigma factor is required for transcription of target genes, prevention of sigma factor synthesis would prevent increased target gene expression; however, if degradation of FpvR~20~ releases active sigma factor, chloramphenicol would not prevent induction of target gene expression.

The results are shown in **Figure [6A](#F6){ref-type="fig"}** and Supplementary Figure [S5A](#SM2){ref-type="supplementary-material"}. Addition of chloramphenicol prevented pyoverdine-mediated induction of expression of *pvdH* and *pvdL*, indicating that σ^PvdS^ must be synthesized in the absence of FpvR~20~ for *pvd* gene expression to occur. Induction of *fpvA* gene expression was not prevented by the presence of chloramphenicol, indicating that degradation of FpvR~20~ released active σ^FpvI^ that could direct transcription of *fpvA*. The slight delay in induction of expression of *fpvA* in the presence of chloramphenicol may indicate that σ^FpvI^ released from degraded FpvR~20~ would normally be supplemented by newly synthesized σ^FpvI^ during pyoverdine-mediated induction of gene expression.

![Effect of chloramphenicol on induction of gene expression. Chloramphenicol (Cm) and then pyoverdine were added to *P. aeruginosa* PAO1 *pvdF* bacteria (0 min) and samples were collected at intervals. **(A)** Samples were analyzed by RT-qPCR for *pvdH*, *pvdL*, and *fpvA*. Open squares, Cm present; Black squares, Cm absent. Data are means of six technical replicates with standard deviation shown. **(B)** Samples were analyzed by Western blotting for σ^PvdS^ or FpvR~20~ in the presence or absence of pyoverdine, as shown. FpvR~20~, σ^PvdS^ (full-size), PvdS~15~ and RpoD are indicated. Times are shown in minutes. Similar results were obtained when the experiment was repeated (Supplementary Figure [S5](#SM2){ref-type="supplementary-material"}).](fmicb-08-02442-g006){#F6}

The effect of chloramphenicol on protein amounts was also investigated (**Figure [6B](#F6){ref-type="fig"}**). In the presence of pyoverdine FpvR~20~ was rapidly degraded, as expected and as also occurred in the absence of chloramphenicol (**Figure [2](#F2){ref-type="fig"}**). In the absence of pyoverdine the amount of FpvR~20~ per cell did not greatly decrease for at least 60 min following addition of chloramphenicol. The continuing presence of FpvR~20~ in the absence of protein synthesis indicates that this protein is relatively stable under these conditions.

In the absence of pyoverdine and consequent presence of FpvR~20~, the amount of σ^PvdS^ decreased after the addition of chloramphenicol (**Figure [6B](#F6){ref-type="fig"}** and Supplementary Figure [S5B](#SM2){ref-type="supplementary-material"}). The amount of PvdS~15~ formed from σ^PvdS^ did not vary during the course of the experiment suggesting that the rates of formation and degradation of PvdS~15~ are similar. The decrease in the amount of σ^PvdS^ was slower following the addition of pyoverdine and consequent absence of FpvR~20~. These results indicate that FpvR~20~ accelerates, but is not essential for, degradation of σ^PvdS^.

Discussion
==========

In this research we show that degradation of the FpvR~20~ antisigma protein in the pyoverdine CSS pathway occurs within 1 min of addition of pyoverdine with expression of the *pvd* and *fpvA* target genes being maximal by 30 min. Target gene expression is dependent on ClpP protease for removal of FpvR~20~ antisigma activity and requires *de novo* synthesis of σ^PvdS^, but not σ^FpvI^.

The time-course of antisigma degradation has previously been examined for the *E. coli* stress response ECF sigma-antisigma system, in which antisigma RseA inhibits the activity of sigma factor σ^E^. RseA has a half-life of about 8 min in uninduced bacteria and 1--2 min following heat-induced envelope stress ([@B1]; [@B8]). In the absence of the pyoverdine inducing signal there was no detectable reduction in the amount of FpvR~20~ over at least 60 min when chloramphenicol was present to prevent new protein synthesis (**Figure [6B](#F6){ref-type="fig"}**), indicating that FpvR~20~ has a long half-life under non-inducing conditions. In contrast, FpvR~20~ was almost undetectable 5 min after addition of pyoverdine in the presence of chloramphenicol (**Figure [6B](#F6){ref-type="fig"}**) indicating a much shorter half-life. The rates of degradation of the FpvR~20~ and RseA antisigma proteins in induced and uninduced cells are therefore comparable, in each case allowing a rapid response to the relevant environmental signal. So far as we are aware the time-course of induction of target gene expression has not previously been determined for any CSS system or indeed, any ECF sigma-antisigma system.

The proteolytic cascade that leads to degradation of FpvR~20~ and induction of gene expression requires ClpP protease (**Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}**). A CSS system is therefore part of the expanding repertoire of regulatory pathways in which Clp proteases are required for degradation of an antisigma protein and consequent sigma factor activity ([@B13]; [@B43]). Unfoldase chaperones -- either ClpA or ClpX -- are required to render substrate proteins susceptible to proteolysis by ClpP ([@B24]; [@B29]) and it will be of interest to determine which unfoldase is required for complete degradation of FpvR~20~. In the *clpP* mutant a subfragment of FpvR~20~, FpvR~12~, is present that is presumably formed by proteolysis of FpvR~20~ and is further degraded by a ClpP-containing protease in ClpP^+^ bacteria. The size of FpvR~12~ indicates that it contains the complete cytoplasmic antisigma domain of FpvR~20~ and so inhibits σ^PvdS^ and σ^FpvI^ ([@B12], [@B11]). This is consistent with the finding that expression of *pvdH*, *pvdL*, and *fpvA* was significantly lower in the *clpP* mutant than in Clp^+^ bacteria in the absence of pyoverdine (**Figure [6](#F6){ref-type="fig"}**). Although FpvR~20~ has a long half-life in the absence of pyoverdine there was a gradual reduction in the amount of FpvR~20~ in the absence of new protein synthesis (**Figure [4](#F4){ref-type="fig"}**). These findings are consistent with proteolytic degradation of FpvR~20~ in wild-type bacteria even in the absence of pyoverdine. Auto-inducing systems such as the pyoverdine CSS system require a basal level of gene expression in order to produce and detect the inducing signal. In the pyoverdine system, some degradation of FpvR~20~ in the absence of pyoverdine is evidently necessary for low-level sigma factor activity to provide basal expression of *fpvA* and *pvd* genes that is needed for up-regulation of gene expression when pyoverdine is present.

The simplest model for sigma factor activation in sigma-antisigma systems is that degradation of the antisigma protein results in release of active sigma factor and consequent gene expression ([@B6]; [@B15]). So far as we are aware, this model has not been directly tested for any sigma/antisigma pair. Our data indicate that σ^PvdS^ must be synthesized in the absence of the FpvR~20~ antisigma in order for expression of *pvd* target genes to occur following addition of pyoverdine (**Figure [6](#F6){ref-type="fig"}**). This demonstrates an alternative model, in which a sigma factor must be synthesized in the absence of its cognate antisigma in order to be active. The presence of FpvR~20~ is associated with proteolysis of σ^PvdS^ that generates a subfragment (PvdS~15~), a likely intermediate in the proteolytic degradation of σ^PvdS^, resulting in a lower amount of σ^PvdS^ per cell when FpvR~20~ is present (**Figure [3](#F3){ref-type="fig"}**) ([@B35]). Proteolysis of σ^PvdS^ in the presence of FpvR~20~ may partially explain the requirement for sigma factor synthesis in the absence of FpvR~20~ in order for the σ^PvdS^ to be active and for target gene expression to occur following addition of pyoverdine. Conversely induction of the σ^FpvI^-dependent *fpvA* gene did not require new protein synthesis (**Figure [4A](#F4){ref-type="fig"}**) showing that in this case, degradation of FpvR~20~ did result in release of active sigma factor. This is consistent with the cellular level of σ^FpvI^ being unaffected by the presence of FpvR~20~ ([@B11]) indicating that FpvR~20~ does not trigger degradation of σ^FpvI^. It will be of interest to determine whether other ECF sigma factors must, like σ^PvdS^, be synthesized in the absence of the cognate anti-sigma in order to be active. A mutation in *clpP* or in the gene encoding Lon protease that degrades a number of regulatory proteins ([@B39]) did not prevent formation of PvdS~15~ (**Figure [5](#F5){ref-type="fig"}** and Supplementary Figure [S6](#SM2){ref-type="supplementary-material"}). The protease that catalyzes the formation of PvdS~15~ from σ^PvdS^ therefore remains to be identified.

Conclusion
==========

Our results demonstrate the speed with which a CSS system can respond to the presence of the inducing signal and the importance of ClpP protease in this process. They also show that induction of gene expression in an ECF sigma-antisigma system can require synthesis of sigma factor in the absence of antisigma, rather than release of active sigma factor following degradation of the antisigma. The molecular mechanisms that initiate degradation of FpvR~20~ and presumably involve its interaction with FpvA remain to be elucidated.
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